Altera Digital Health Launches Sunrise CarePath Patient Engagement Platform
BUSINESS WIRE)-- Altera Digital Health, a global health IT leader, today announced the launch of Sunrise™ CarePath, a mobile patient engagement platform designed to close communication gaps and reduce adverse events, readmissions and financial barriers. Fully integrated with the Sunrise™ EHR, Sunrise CarePath delivers capabilities including real-time secure messaging, self-scheduling, patient notifications and appointment reminders, and online billing integration. Sunrise CarePath, compatible with version 22.1, is now generally available to mid-size hospital and health system clients.
Research suggests approximately 20% of patients experience adverse events within three weeks of hospital discharge, many of which are preventable. To bolster patient-provider communication, during and beyond the critical post-discharge period, Sunrise CarePath includes on-demand messaging that connects patients to care team members. Enabling patients to quickly clarify discharge instructions and report side effects in real time will help prevent avoidable emergency department (ED) visits and readmissions while also supporting patient confidence and continuity of care.
Sunrise CarePath also offers instant appointment management and intelligent rescheduling/cancellation capabilities to help reduce missed appointments hindering proper medication management, timely interventions, care quality and hospital revenue. To further empower patients and encourage care plan adherence, Sunrise CarePath includes notifications for new health data and appointment reminders customized to the patient's communication preferences. Additionally, Sunrise CarePath integrates with hospital bill pay pages, enabling patients to pay medical bills in a paperless, convenient and secure manner. This removes friction from the patient financial experience and speeds up revenue collection, while also reducing administrative burdens for healthcare organizations.
"When patients can't easily message their care team, manage follow-up appointments or stay on track with medications, adverse events are inevitable,' said Jay Adams, Executive Vice President and General Manager for Sunrise, Altera Digital Health. 'Sunrise CarePath gives hospitals powerful tools to close these gaps—helping clinicians protect patients and drive better outcomes after discharge. This level of engagement is key to delivering truly patient-centric care.'
About Altera Digital Health
A global healthcare IT leader, Altera Digital Health develops and elevates technology to bring next-level healthcare within reach. Altera's approach to our solutions is changing the way healthcare is delivered—we see the summit of what healthcare can be, but rather than total transformation, we're focused on helping organizations take the steps they need to get there. Altera designs digital health services that lead healthcare to a higher place, while we guide those we partner with, all along the way. To learn more, visit www.alterahealth.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine
WALTHAM, Mass., June 25, 2025--(BUSINESS WIRE)--Minerva Biotechnologies published, "The Wnt pathway induces a naïve-like subpopulation in primed stem cells, while NME7AB leads to a homogeneous naïve-like population," in the journal PLOS One, These studies shed light on the scientific controversy of whether activation of the Wnt/β-catenin pathway induces human stem cell pluripotency or differentiation. The literature is replete with contradictory conclusions, based on what appear to be sound scientific studies. Others reported that low levels of β-catenin skew differentiation down neuroectoderm, whereas high levels favor differentiation down mesendoderm. Recently two research groups independently found that "boosting" β-catenin just prior to differentiation improved differentiation of both neuroectoderm and mesendoderm. Unexpectedly, our studies found that, in the absence of other growth factors, activation of the Wnt/β-catenin pathway induced two segregated populations: islands of naïve OCT4+ XaXa cells (both X chromosomes active) in a sea of differentiating OCT4- XaXi cells (one X chromosome inactivated). Like others, we found that activating the β-catenin pathway before or at the initiation of differentiation greatly improved the differentiation of primed state stem cells but had no effect on NME7 AB naïve state stem cells. The differentiation of homogeneous populations of NME7 AB induced naïve state stem cells was superior to that of primed state stem cells, even if the β-catenin pathway was activated before differentiation. For example, induced pluripotent stem cells (iPSC) generated in, then expanded in GMP compliant minimal media containing recombinant NME7AB as the only growth factor, differentiated with high efficiency into mesenchymal stem cells (MSCs). Unlike other attempts, Minerva's iPSC-derived MSCs resisted senescing and each clone could differentiate into essentially pure populations of chondrocytes, osteoblasts or adipocytes that could be useful for repair or replacement of cartilage, bone or fat. "These data represent a major breakthrough for the large-scale, GMP compliant manufacture of patient-derived MSCs for therapeutic uses," said Dr. Cynthia Bamdad, CEO of Minerva Biotechnologies, "and will replace the practice of using MSCs harvested from bone marrow of unknown, often untested donors." View source version on Contacts Minerva BiotechnologiesRon Axelrodraxelrod@ 617-785-9491 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine
WALTHAM, Mass.--(BUSINESS WIRE)--Minerva Biotechnologies published, 'The Wnt pathway induces a naïve-like subpopulation in primed stem cells, while NME7 AB leads to a homogeneous naïve-like population,' in the journal PLOS One, These studies shed light on the scientific controversy of whether activation of the Wnt/β-catenin pathway induces human stem cell pluripotency or differentiation. The literature is replete with contradictory conclusions, based on what appear to be sound scientific studies. Others reported that low levels of β-catenin skew differentiation down neuroectoderm, whereas high levels favor differentiation down mesendoderm. Recently two research groups independently found that 'boosting' β-catenin just prior to differentiation improved differentiation of both neuroectoderm and mesendoderm. Unexpectedly, our studies found that, in the absence of other growth factors, activation of the Wnt/β-catenin pathway induced two segregated populations: islands of naïve OCT4+ XaXa cells (both X chromosomes active) in a sea of differentiating OCT4- XaXi cells (one X chromosome inactivated). Like others, we found that activating the β-catenin pathway before or at the initiation of differentiation greatly improved the differentiation of primed state stem cells but had no effect on NME7 AB naïve state stem cells. The differentiation of homogeneous populations of NME7 AB induced naïve state stem cells was superior to that of primed state stem cells, even if the β-catenin pathway was activated before differentiation. For example, induced pluripotent stem cells (iPSC) generated in, then expanded in GMP compliant minimal media containing recombinant NME7 AB as the only growth factor, differentiated with high efficiency into mesenchymal stem cells (MSCs). Unlike other attempts, Minerva's iPSC-derived MSCs resisted senescing and each clone could differentiate into essentially pure populations of chondrocytes, osteoblasts or adipocytes that could be useful for repair or replacement of cartilage, bone or fat. 'These data represent a major breakthrough for the large-scale, GMP compliant manufacture of patient-derived MSCs for therapeutic uses,' said Dr. Cynthia Bamdad, CEO of Minerva Biotechnologies, 'and will replace the practice of using MSCs harvested from bone marrow of unknown, often untested donors.'
Business Wire
an hour ago
- Business Wire
LookDeep Health Platform Launches New Capabilities to Reduce Workplace Violence in Healthcare Facilities
BUSINESS WIRE)-- LookDeep Health today announced new AI capabilities to protect hospital care teams from workplace violence. LookDeep has added new functions to its AI-driven platform to upgrade safety from reactive notification to proactive prevention, enabling video-based security protocols to use AI to flag and prevent potential attacks. Healthcare workers represent just 10% of the U.S. labor force, yet they suffer nearly half of all reported non‑fatal injuries caused by workplace violence. Two nurses are assaulted in an acute‑care setting every hour. Events such as the February 2025 hostage‑taking at a Pennsylvania ICU that left a police officer dead now make national headlines. Protecting professionals who dedicate their lives to caring for others isn't just a moral imperative — it impacts workforce retention, patient care quality, and hospital finances. 'Violence in a patient room rarely comes out of nowhere—it follows a rapid yet recognizable progression,' said Narinder Singh, Founder and CEO of LookDeep. 'Tension builds through agitated movements, raised voices, and escalating behaviors. Clinicians sense rising danger and may call for help. If uninterrupted, these situations can quickly turn harmful. With AI, we can support clinicians exactly when they call for assistance—and even earlier—by sensing risk and providing an extra set of eyes or timely intervention to help de-escalate before an incident occurs. We can use the same technology hospitals already need for telemedicine to better care for the nurses and doctors that care for our loved ones.' The LookDeep platform now includes multiple key features to keep nurses, clinicians, and staff (as well as patients) safe from violence in the care center. These include: Voice Activation of Indirect or Directed Help Words - Staff can ask for help when they feel like they need it in an overt or subtle way. AI-Powered Situational Awareness - Modern computer‑vision platforms turn the video infrastructure many facilities already use for tele‑ICU, telesitting, and virtual nursing into a continuous safety net, providing ambient awareness. Voice and Vision are used to flag rooms where tensions are escalating even prior to staff requests for help. Real-Time Location Systems (RTLS) integration: Wearable badges allow staff to silently call for help when under duress. Paired with the AI-driven LookDeep platform, hospitals can directly link their systems to detect and respond to threats much faster. About LookDeep Health LookDeep Health is reshaping hospital care with advanced computer vision and AI technology to create a safer and more efficient environment for patients and providers. VisionAI Agents work alongside hospital staff to continuously monitor patients, alerting clinicians to potential risks to help improve care outcomes. By integrating these capabilities into virtual sitting, virtual nursing, and virtual medicine, LookDeep enhances patient safety, reduces staff strain, and improves hospital efficiency – helping facilities cut operational costs while elevating the quality of care. Learn more at
